168 related articles for article (PubMed ID: 22218843)
1. RCT of montelukast as prophylaxis for upper respiratory tract infections in children.
Kozer E; Lotem Z; Elgarushe M; Torgovicky R; Cohen R; Cohen HA; Berkovitch M
Pediatrics; 2012 Feb; 129(2):e285-90. PubMed ID: 22218843
[TBL] [Abstract][Full Text] [Related]
2. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
Wahn U; Dass SB
Clin Ther; 2008; 30 Spec No():1026-35. PubMed ID: 18640477
[TBL] [Abstract][Full Text] [Related]
3. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma.
Bisgaard H; Zielen S; Garcia-Garcia ML; Johnston SL; Gilles L; Menten J; Tozzi CA; Polos P
Am J Respir Crit Care Med; 2005 Feb; 171(4):315-22. PubMed ID: 15542792
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma.
van Adelsberg J; Moy J; Wei LX; Tozzi CA; Knorr B; Reiss TF
Curr Med Res Opin; 2005 Jun; 21(6):971-9. PubMed ID: 15969897
[TBL] [Abstract][Full Text] [Related]
5. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.
Nayak AS; Philip G; Lu S; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2002 Jun; 88(6):592-600. PubMed ID: 12086367
[TBL] [Abstract][Full Text] [Related]
7. Short-course montelukast for intermittent asthma in children: a randomized controlled trial.
Robertson CF; Price D; Henry R; Mellis C; Glasgow N; Fitzgerald D; Lee AJ; Turner J; Sant M
Am J Respir Crit Care Med; 2007 Feb; 175(4):323-9. PubMed ID: 17110643
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
[TBL] [Abstract][Full Text] [Related]
9. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
[TBL] [Abstract][Full Text] [Related]
10. Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.
Razi C; Bakirtas A; Harmanci K; Turktas I; Erbas D
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):767-74. PubMed ID: 17201236
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.
Patel P; Philip G; Yang W; Call R; Horak F; LaForce C; Gilles L; Garrett GC; Dass SB; Knorr BA; Reiss TF
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):551-7. PubMed ID: 16400895
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
Johnston NW; Mandhane PJ; Dai J; Duncan JM; Greene JM; Lambert K; Sears MR
Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
[TBL] [Abstract][Full Text] [Related]
13. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial.
Todi VK; Lodha R; Kabra SK
Arch Dis Child; 2010 Jul; 95(7):540-3. PubMed ID: 20522464
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice MP; Reiss TF;
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):214-22. PubMed ID: 12602669
[TBL] [Abstract][Full Text] [Related]
15. Effect of montelukast on peripheral airflow obstruction in children with asthma.
Spahn JD; Covar RA; Jain N; Gleason M; Shimamoto R; Szefler SJ; Gelfand EW
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
[TBL] [Abstract][Full Text] [Related]
16. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions.
Bisgaard H; Skoner D; Boza ML; Tozzi CA; Newcomb K; Reiss TF; Knorr B; Noonan G
Pediatr Pulmonol; 2009 Jun; 44(6):568-79. PubMed ID: 19449366
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
Szefler SJ; Baker JW; Uryniak T; Goldman M; Silkoff PE
J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
20. [The effectiveness of montelukast in recurrent post-bronchiolitis wheezing].
Nanulescu M; Popescu L; Farcău M; Ichim G
Pneumologia; 2003; 52(3-4):213-6. PubMed ID: 18210737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
